Pages that link to "Q47605536"
Jump to navigation
Jump to search
The following pages link to Donor CD4 T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations (Q47605536):
Displaying 50 items.
- Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients (Q24187102) (← links)
- Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients (Q24200272) (← links)
- Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients (Q24202963) (← links)
- Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients (Q26787230) (← links)
- The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview (Q28066083) (← links)
- The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease (Q28076264) (← links)
- Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease (Q33385079) (← links)
- Combined meta-analysis of systemic effects of allogeneic stem cell transplantation and systemic sclerosis (Q33614372) (← links)
- Identification of MHC II-Restricted Minor Histocompatibility Antigens After HLA-Identical Stem-Cell Transplantation (Q33677067) (← links)
- Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease (Q33725411) (← links)
- Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice (Q33792598) (← links)
- Chronic graft-versus-host disease (GVHD) in children. (Q33857680) (← links)
- Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects (Q33905411) (← links)
- Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8 T cells mediating graft-versus-host disease (Q34033248) (← links)
- High levels of B-cell activating factor in patients with active chronic graft-versus-host disease (Q34135089) (← links)
- Treatment of chronic graft-versus-host disease with bortezomib (Q34137032) (← links)
- STAT3 signaling in CD4 T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model (Q34139886) (← links)
- B cells and transplantation: an educational resource (Q34152189) (← links)
- Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study (Q34255166) (← links)
- Thymic T-cell development in allogeneic stem cell transplantation (Q35083246) (← links)
- The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma (Q35084404) (← links)
- Recipient B cells are not required for graft-versus-host disease induction (Q35104223) (← links)
- Aberrant B-cell homeostasis in chronic GVHD (Q35171251) (← links)
- Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity (Q35691842) (← links)
- Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice (Q35766798) (← links)
- Clinical applications for biomarkers of acute and chronic graft-versus-host disease (Q35767289) (← links)
- Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans (Q35776453) (← links)
- Regulation of pulmonary graft-versus-host disease by IL-26 CD26 CD4 T lymphocytes (Q36056986) (← links)
- Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease (Q36058558) (← links)
- Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. (Q36491894) (← links)
- Understanding chronic GVHD from different angles (Q36551588) (← links)
- Murine models of chronic graft-versus-host disease: insights and unresolved issues (Q36645730) (← links)
- Chronic graft-versus-host disease in the era of reduced-intensity conditioning (Q36766430) (← links)
- Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease (Q36843812) (← links)
- In vivo-activated CD103 CD4 regulatory T cells ameliorate ongoing chronic graft-versus-host disease (Q36843821) (← links)
- Antibodies are back for thymic attack in cGVHD. (Q36876960) (← links)
- Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice. (Q36876981) (← links)
- IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation (Q36923019) (← links)
- Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? (Q37035815) (← links)
- Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease. (Q37064425) (← links)
- Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4 and CD8 T cells (Q37104254) (← links)
- Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4 T cells that mediate autoimmune-like chronic graft-versus-host disease. (Q37104281) (← links)
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease (Q37162874) (← links)
- Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients (Q37206377) (← links)
- Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab (Q37246752) (← links)
- Immune modulation and chronic graft-versus-host disease (Q37251057) (← links)
- TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors (Q37291642) (← links)
- Biology of chronic graft-versus-host disease: implications for a future therapeutic approach (Q37294468) (← links)
- The immunopathology of thymic GVHD. (Q37313942) (← links)
- Alloimmune Response Results in Expansion of Autoreactive Donor CD4 T Cells in Transplants That Can Mediate Chronic Graft-versus-Host Disease (Q37479204) (← links)